UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 202

Sortiert nach

Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort

International Journal of Obesity, 2013-04, Vol.37 (4), p.598-603

2013

Volltextzugriff (PDF)

Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI

The New England journal of medicine, 2017-05, Vol.376 (19), p.1813-1823

2017

Volltextzugriff (PDF)

Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction

The New England journal of medicine, 2013-10, Vol.369 (17), p.1587-1597

2013

Volltextzugriff (PDF)

Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden

The New England journal of medicine, 2009-05, Vol.360 (19), p.1933-1945

2009

Volltextzugriff (PDF)

Pool exercise for patients with fibromyalgia or chronic widespread pain: a randomized controlled trial and subgroup analyses

Journal of rehabilitation medicine, 2009-09, Vol.41 (9), p.751-760

2009

Volltextzugriff (PDF)

Incident cardiovascular disease in women with type 1 or type 2 diabetes by history of hypertensive disorders of pregnancy

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

COPEPTIN, A PREDICTOR OF CARDIOMETABOLIC RISK FACTORS AND ORGAN DAMAGE: PP.9.221

Journal of hypertension, 2011-06, Vol.29, p.e213

2011

Volltextzugriff (PDF)

P189 La vasopressine dégrade la tolérance au glucose dans un modèle de rats présentant un syndrome métabolique

Diabetes & metabolism, 2014-03, Vol.40, p.A73-A73

2014

Volltextzugriff (PDF)

P225 La vasopressine augmente la glycémie à jeun de façon chronique : un nouvel acteur du contrôle de l’homéostasie glucidique

Diabetes & metabolism, 2012-03, Vol.38, p.A84-A84

2012

Volltextzugriff (PDF)

Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

European heart journal, 2010-01, Vol.31 (2), p.177-186

2010

Volltextzugriff (PDF)

Investigation of possible underlying mechanisms behind water-induced glucose reduction in adults with high copeptin

Scientific reports, 2021-12, Vol.11 (1), p.24481-24481, Article 24481

2021

Volltextzugriff (PDF)

Plasma Copeptin and the Risk of Diabetes Mellitus

Circulation (New York, N.Y.), 2010-05, Vol.121 (19), p.2102-2108

2010

Volltextzugriff (PDF)

The association between water intake and future cardiometabolic disease outcomes in the Malmö Diet and Cancer cardiovascular cohort

PloS one, 2024-01, Vol.19 (1), p.e0296778-e0296778

2024

Volltextzugriff (PDF)

High water intake and low urine osmolality are associated with favorable metabolic profile at a population level: low vasopressin secretion as a possible explanation

European journal of nutrition, 2020-12, Vol.59 (8), p.3715-3722

2020

Volltextzugriff (PDF)

The possible role of the vasopressin system in hematopoiesis

Scientific reports, 2024-03, Vol.14 (1), p.5085-5085, Article 5085

2024

Volltextzugriff (PDF)

The association of copeptin with metabolic risk markers is modified by region of origin

Scientific reports, 2023-11, Vol.13 (1), p.19651-8, Article 19651

2023

Volltextzugriff (PDF)

Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome

The journal of clinical endocrinology and metabolism, 2011-07, Vol.96 (7), p.E1065-E1072

2011

Volltextzugriff (PDF)

Effect of increased water intake on plasma copeptin in healthy adults

European journal of nutrition, 2018-08, Vol.57 (5), p.1883-1890

2018

Volltextzugriff (PDF)

Copeptin is an independent predictor of diabetic heart disease and death

The American heart journal, 2015-04, Vol.169 (4), p.549-556.e1

2015

Volltextzugriff (PDF)

Response to Letter to the Editor: “Water Supplementation Reduces Copeptin and Plasma Glucose in Adults with High Copeptin: The H2O Metabolism Pilot Study”

The journal of clinical endocrinology and metabolism, 2020-02, Vol.105 (2), p.576-577

2020

Volltextzugriff (PDF)

Plasma copeptin as a predictor of kidney disease

Nephrology, dialysis, transplantation, 2019-01, Vol.34 (1), p.74-82

2019

Volltextzugriff (PDF)

Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus

European journal of endocrinology, 2016-01, Vol.174 (1), p.69

2016

Volltextzugriff (PDF)

The Vasopressin System in the Risk of Diabetes and Cardiorenal Disease, and Hydration as a Potential Lifestyle Intervention

Annals of nutrition and metabolism, 2018-01, Vol.72 (Suppl 2), p.21-27

2018

Volltextzugriff (PDF)

Incident Cardiovascular Disease in Women With Type 1 or Type 2 Diabetes Following a Hypertensive Disorder of Pregnancy

Hypertension (Dallas, Tex. 1979), 2024-04, Vol.81 (4), p.897

2024

Volltextzugriff (PDF)

Copeptin as a marker of atherosclerosis and arteriosclerosis

Atherosclerosis, 2021-12, Vol.338, p.64-68

2021

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort

Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI

Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction

Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden

Pool exercise for patients with fibromyalgia or chronic widespread pain: a randomized controlled trial and subgroup analyses

Incident cardiovascular disease in women with type 1 or type 2 diabetes by history of hypertensive disorders of pregnancy

COPEPTIN, A PREDICTOR OF CARDIOMETABOLIC RISK FACTORS AND ORGAN DAMAGE: PP.9.221

P189 La vasopressine dégrade la tolérance au glucose dans un modèle de rats présentant un syndrome métabolique

P225 La vasopressine augmente la glycémie à jeun de façon chronique : un nouvel acteur du contrôle de l’homéostasie glucidique

Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Investigation of possible underlying mechanisms behind water-induced glucose reduction in adults with high copeptin

Plasma Copeptin and the Risk of Diabetes Mellitus

The association between water intake and future cardiometabolic disease outcomes in the Malmö Diet and Cancer cardiovascular cohort

High water intake and low urine osmolality are associated with favorable metabolic profile at a population level: low vasopressin secretion as a possible explanation

The possible role of the vasopressin system in hematopoiesis

The association of copeptin with metabolic risk markers is modified by region of origin

Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome

Effect of increased water intake on plasma copeptin in healthy adults

Copeptin is an independent predictor of diabetic heart disease and death

Response to Letter to the Editor: “Water Supplementation Reduces Copeptin and Plasma Glucose in Adults with High Copeptin: The H2O Metabolism Pilot Study”

Plasma copeptin as a predictor of kidney disease

Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus

The Vasopressin System in the Risk of Diabetes and Cardiorenal Disease, and Hydration as a Potential Lifestyle Intervention

Incident Cardiovascular Disease in Women With Type 1 or Type 2 Diabetes Following a Hypertensive Disorder of Pregnancy

Copeptin as a marker of atherosclerosis and arteriosclerosis

Suchergebnisse filtern